Mark-Andre Freyberg
Plus aucun poste en cours
Profil
Mark-Andre Freyberg is the founder of Dermatools Biotech GmbH (founded in 2004), Cytopharma GmbH (founded in 2006), and bioXXmed AG (founded in 2000).
At bioXXmed AG, he held the title of Chief Executive Officer from 2000 to 2021.
Dr. Freyberg's former jobs include Chief Executive Officer at TemplaTech GmbH and Project Manager at Technische Universität Darmstadt.
He earned a doctorate degree from Technische Universität Darmstadt.
Anciens postes connus de Mark-Andre Freyberg
| Sociétés | Poste | Fin |
|---|---|---|
| BIOXXMED AG | Chief Executive Officer | 30/09/2021 |
TemplaTech GmbH
 TemplaTech GmbH BiotechnologyHealth Technology TemplaTech GmbH develops biological medical products. It offers therapy for chronic urinary tract diseases. The company is headquartered in Darmstadt, Germany. | President | 03/09/2007 |
| Dermatools Biotech GmbH | Founder | - |
| Cytopharma GmbH | Founder | - |
| Technische Universität Darmstadt | Corporate Officer/Principal | - |
Formation de Mark-Andre Freyberg
| Technische Universität Darmstadt | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOXXMED AG | Health Technology |
| Entreprise privées | 3 |
|---|---|
TemplaTech GmbH
TemplaTech GmbH BiotechnologyHealth Technology TemplaTech GmbH develops biological medical products. It offers therapy for chronic urinary tract diseases. The company is headquartered in Darmstadt, Germany. | Health Technology |
| Dermatools Biotech GmbH | |
| Cytopharma GmbH |
